NZ232499A - Pharmaceutical composition comprising 5-(2-chloro-ethyl)-4-methylthiazole - Google Patents
Pharmaceutical composition comprising 5-(2-chloro-ethyl)-4-methylthiazoleInfo
- Publication number
- NZ232499A NZ232499A NZ232499A NZ23249990A NZ232499A NZ 232499 A NZ232499 A NZ 232499A NZ 232499 A NZ232499 A NZ 232499A NZ 23249990 A NZ23249990 A NZ 23249990A NZ 232499 A NZ232499 A NZ 232499A
- Authority
- NZ
- New Zealand
- Prior art keywords
- methylthiazole
- chloro
- ethyl
- pharmaceutical composition
- chlormethiazole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polymerization Catalysts (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8900564A SE8900564D0 (sv) | 1989-02-17 | 1989-02-17 | Novel medicinal use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ232499A true NZ232499A (en) | 1992-12-23 |
Family
ID=20375091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ232499A NZ232499A (en) | 1989-02-17 | 1990-02-13 | Pharmaceutical composition comprising 5-(2-chloro-ethyl)-4-methylthiazole |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0458892B1 (fr) |
| JP (1) | JP3007683B2 (fr) |
| KR (1) | KR0139221B1 (fr) |
| AT (1) | ATE107166T1 (fr) |
| AU (1) | AU643431B2 (fr) |
| CA (1) | CA2045618A1 (fr) |
| DE (1) | DE69009989T2 (fr) |
| DK (1) | DK0458892T3 (fr) |
| ES (1) | ES2055421T3 (fr) |
| HK (1) | HK44597A (fr) |
| IE (1) | IE64622B1 (fr) |
| IL (1) | IL93243A (fr) |
| NZ (1) | NZ232499A (fr) |
| PH (1) | PH26372A (fr) |
| SE (1) | SE8900564D0 (fr) |
| WO (1) | WO1990009174A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP921128B1 (en) * | 1991-10-30 | 1998-10-31 | Sandor Garaczy | Novel process for the preparation of 4-methyl-5(2-chloroethyl)-thiazole and analogues thereof |
| SE9802119D0 (sv) * | 1998-06-15 | 1998-06-15 | Astra Ab | New use |
| SE9901658D0 (sv) * | 1999-05-06 | 1999-05-06 | Astra Ab | New formulation |
| SE9904177D0 (sv) * | 1999-11-18 | 1999-11-18 | Astra Ab | Novel compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE196140C1 (fr) * | 1964-01-01 |
-
1989
- 1989-02-17 SE SE8900564A patent/SE8900564D0/xx unknown
-
1990
- 1990-02-01 IL IL9324390A patent/IL93243A/en not_active IP Right Cessation
- 1990-02-09 IE IE46090A patent/IE64622B1/en not_active IP Right Cessation
- 1990-02-12 PH PH40041A patent/PH26372A/en unknown
- 1990-02-13 AU AU51679/90A patent/AU643431B2/en not_active Ceased
- 1990-02-13 ES ES90903980T patent/ES2055421T3/es not_active Expired - Lifetime
- 1990-02-13 DK DK90903980.2T patent/DK0458892T3/da active
- 1990-02-13 AT AT90903980T patent/ATE107166T1/de not_active IP Right Cessation
- 1990-02-13 DE DE69009989T patent/DE69009989T2/de not_active Expired - Lifetime
- 1990-02-13 NZ NZ232499A patent/NZ232499A/xx unknown
- 1990-02-13 EP EP90903980A patent/EP0458892B1/fr not_active Expired - Lifetime
- 1990-02-13 CA CA002045618A patent/CA2045618A1/fr not_active Withdrawn
- 1990-02-13 WO PCT/SE1990/000093 patent/WO1990009174A1/fr not_active Ceased
- 1990-02-13 JP JP2503995A patent/JP3007683B2/ja not_active Expired - Lifetime
-
1991
- 1991-08-16 KR KR91700916A patent/KR0139221B1/ko not_active Expired - Fee Related
-
1997
- 1997-04-10 HK HK44597A patent/HK44597A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0458892A1 (fr) | 1991-12-04 |
| WO1990009174A1 (fr) | 1990-08-23 |
| DK0458892T3 (da) | 1994-08-15 |
| CA2045618A1 (fr) | 1990-08-18 |
| JP3007683B2 (ja) | 2000-02-07 |
| DE69009989D1 (de) | 1994-07-21 |
| KR920700641A (ko) | 1992-08-10 |
| ATE107166T1 (de) | 1994-07-15 |
| HK44597A (en) | 1997-04-18 |
| IE64622B1 (en) | 1995-08-23 |
| SE8900564D0 (sv) | 1989-02-17 |
| ES2055421T3 (es) | 1994-08-16 |
| AU5167990A (en) | 1990-09-05 |
| IL93243A0 (en) | 1990-11-29 |
| EP0458892B1 (fr) | 1994-06-15 |
| PH26372A (en) | 1992-06-01 |
| IE900460L (en) | 1990-08-17 |
| IL93243A (en) | 1994-08-26 |
| KR0139221B1 (en) | 1998-05-15 |
| DE69009989T2 (de) | 1994-10-13 |
| AU643431B2 (en) | 1993-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO900613D0 (no) | Fremgangsmaate for fremstilling av aktiverte chitosaner oganvendelse ved fremstilling av chitosanderivater. | |
| ZA908953B (en) | Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole | |
| ZA896864B (en) | Method and composition for the treatment and prevention of viral infections | |
| GB8900678D0 (en) | Compositions for the prevention and medical treatment of parodonthopathy | |
| FI923548A7 (fi) | Vaahtoa muodostava koostumus farmaseuttiseen käyttöön, sen käyttö ja h oitomenetelmä | |
| PH31600A (en) | Methods of inhibiting atrophy of the skin and vagina. | |
| ZA90684B (en) | Insecticide treatment and compositions therefor | |
| IL106521A0 (en) | Pharmaceutical composition for the treatment or prevention of elevated intraocular pressure | |
| NO893142D0 (no) | Fremgangsmaate for preservering av oftalmologiske opploesninger og sammensetninger for formaalet. | |
| ZA845670B (en) | Coumarin derivatives,pharmaceutical compositions containing the same,and the use thereof in the treatment of cancer | |
| DE69024047D1 (de) | Nimbaumöl enthaltende Zusammensetzung zur Fertilitätskontrolle und zur Schwangerschaftsverhütung. | |
| NZ232499A (en) | Pharmaceutical composition comprising 5-(2-chloro-ethyl)-4-methylthiazole | |
| EP0437026A3 (en) | Use of tandospirone in the treatment of depression | |
| GB9010058D0 (en) | Method and composition for the treatment of cancer | |
| AU6527390A (en) | Pharmaceutical compositions for the treatment of ataxy and equilibrium problems | |
| FI944687A7 (fi) | Koostumus likinäköisyyden ennaltaehkäisemiseksi ja hoitamiseksi | |
| AU2591188A (en) | Activating material composed mainly of animal bone, flocculating agent composed mainly of the material and processes for preparation thereof | |
| IL96455A0 (en) | Pharmaceutical compositions for the treatment of hsv | |
| NO905543L (no) | Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer. | |
| IL68422A0 (en) | Hydantoin derivatives and their use in medicine | |
| KR900007413A (ko) | 에이즈 발병방지, 치료제 및 그 치료용 조성물 | |
| IT8919204A0 (it) | Composizione per la prevenzione e la cura di parodontopatte. | |
| ZA893275B (en) | Pharmaceutical composition for the treatment of migraine and the like | |
| KR920005980A (ko) | 팽창선 병변의 예방 및 이의 크기를 감소시키기 위한 약제학적 조성물 | |
| NO923078D0 (no) | Skumbar sammensetning for farmasoeytisk anvendelse, anvendelse derav og fremgangsmaate for behandling |